Literature DB >> 27326655

Is there still room for additional common susceptibility alleles for venous thromboembolism?

D A Trégouët1,2, A Delluc3, A Roche4,5,6, C Derbois7, R Olaso7, M Germain8,9, M de Andrade10, W Tang11, D I Chasman12, A van Hylckama Vlieg13, P H Reitsma14, C Kabrhel15, N Smith16,17,18, P E Morange19,20.   

Abstract

UNLABELLED: Essentials Genetic architecture of venous thromboembolism (VTE) remains to be fully disentangled. 11 newly discovered candidate polymorphisms were genotyped in 3019 VTE cases and 2605 controls. None of the 11 polymorphisms were significantly associated with VTE risk. Additional major efforts are needed to identify VTE-associated genetic variants.
SUMMARY: Background Through a meta-analysis of 12 genome-wide association studies, the International Network against VENous Thrombosis (INVENT) consortium identified two novel susceptibility loci for venous thromboembolism (VTE). This project has also generated other candidates that need to be confirmed. Objectives To assess the association with VTE of common single-nucleotide polymorphisms (SNPs) that demonstrated strong statistical, but not genome-wide, significance in the INVENT cohorts. Patients/methods Eleven SNPs were genotyped and tested for association with VTE in three case-control studies totaling 3019 patients and 2605 healthy individuals. Results and conclusions None of the tested SNPs showed evidence for association with VTE. Different strategies are needed to decipher the whole spectrum of common and rare genetic variations associated with VTE risk.
© 2016 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  genetic polymorphisms; genome-wide association study; meta-analysis; risk factors; venous thromboembolism

Mesh:

Year:  2016        PMID: 27326655      PMCID: PMC5152582          DOI: 10.1111/jth.13392

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  5 in total

1.  Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study.

Authors:  E Oger; K Lacut; G Le Gal; F Couturaud; D Guénet; J-H Abalain; A-M Roguedas; D Mottier
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

2.  Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis.

Authors:  David A Hinds; Alfonso Buil; Daniel Ziemek; Angel Martinez-Perez; Rainer Malik; Lasse Folkersen; Marine Germain; Anders Mälarstig; Andrew Brown; Jose Manuel Soria; Martin Dichgans; Nan Bing; Anders Franco-Cereceda; Juan Carlos Souto; Emmanouil T Dermitzakis; Anders Hamsten; Bradford B Worrall; Joyce Y Tung; Maria Sabater-Lleal
Journal:  Hum Mol Genet       Date:  2016-02-09       Impact factor: 6.150

3.  Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project.

Authors:  Tiphaine Oudot-Mellakh; William Cohen; Marine Germain; Noémie Saut; Choumous Kallel; Diana Zelenika; Mark Lathrop; David-Alexandre Trégouët; Pierre-Emmanuel Morange
Journal:  Br J Haematol       Date:  2012-01-16       Impact factor: 6.998

4.  Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism.

Authors:  Marine Germain; Daniel I Chasman; Hugoline de Haan; Weihong Tang; Sara Lindström; Lu-Chen Weng; Mariza de Andrade; Marieke C H de Visser; Kerri L Wiggins; Pierre Suchon; Noémie Saut; David M Smadja; Grégoire Le Gal; Astrid van Hylckama Vlieg; Antonio Di Narzo; Ke Hao; Christopher P Nelson; Ares Rocanin-Arjo; Lasse Folkersen; Ramin Monajemi; Lynda M Rose; Jennifer A Brody; Eline Slagboom; Dylan Aïssi; France Gagnon; Jean-Francois Deleuze; Panos Deloukas; Christophe Tzourio; Jean-Francois Dartigues; Claudine Berr; Kent D Taylor; Mete Civelek; Per Eriksson; Bruce M Psaty; Jeanine Houwing-Duitermaat; Alison H Goodall; François Cambien; Peter Kraft; Philippe Amouyel; Nilesh J Samani; Saonli Basu; Paul M Ridker; Frits R Rosendaal; Christopher Kabrhel; Aaron R Folsom; John Heit; Pieter H Reitsma; David-Alexandre Trégouët; Nicholas L Smith; Pierre-Emmanuel Morange
Journal:  Am J Hum Genet       Date:  2015-03-12       Impact factor: 11.025

5.  Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.

Authors:  David-Alexandre Trégouët; Simon Heath; Noémie Saut; Christine Biron-Andreani; Jean-François Schved; Gilles Pernod; Pilar Galan; Ludovic Drouet; Diana Zelenika; Irène Juhan-Vague; Marie-Christine Alessi; Laurence Tiret; Mark Lathrop; Joseph Emmerich; Pierre-Emmanuel Morange
Journal:  Blood       Date:  2009-03-10       Impact factor: 22.113

  5 in total
  3 in total

1.  Failure to replicate thrombomodulin genetic variant predictors of venous thromboembolism in African Americans.

Authors:  Aaron R Folsom; Nicholas S Roetker; Spencer T Kelley; Weihong Tang; Nathan Pankratz
Journal:  Blood       Date:  2017-06-15       Impact factor: 22.113

2.  Sensitized mutagenesis screen in Factor V Leiden mice identifies thrombosis suppressor loci.

Authors:  Randal J Westrick; Kärt Tomberg; Amy E Siebert; Guojing Zhu; Mary E Winn; Sarah L Dobies; Sara L Manning; Marisa A Brake; Audrey C Cleuren; Linzi M Hobbs; Lena M Mishack; Alexander J Johnston; Emilee Kotnik; David R Siemieniak; Jishu Xu; Jun Z Li; Thomas L Saunders; David Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

3.  Gene Variants Associated With Venous Thrombosis: A Replication Study in a Brazilian Multicentre Study.

Authors:  Anna Virgínia Calazans Romano; Aline Barnabé; Telma Barbosa Gadelha; João Carlos de Campos Guerra; Rodrigo Secolin; Fernanda Loureiro de Andrade Orsi; Gizele de Castro Sousa Campanate; Nelson Wolosker; Joyce Maria Annichino-Bizzacchi
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.